| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.51 | 0.0004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.51 | 0.001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |